(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1320286 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RPL27A mRNA CTD PMID:22079256 (-)-epigallocatechin 3-gallate increases expression ISO RGD:1320286 6480464 epigallocatechin gallate results in increased expression of RPL27A protein CTD PMID:31195006 (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL27A mRNA CTD PMID:36331819 1,2-dichloroethane increases expression EXP 6480464 ethylene dichloride results in increased expression of RPL27A mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RPL27A mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:1320286 6480464 Dinitrochlorobenzene results in increased expression of RPL27A mRNA CTD PMID:17374397 17alpha-ethynylestradiol increases expression ISO RGD:1309771 6480464 Ethinyl Estradiol results in increased expression of RPL27A mRNA CTD PMID:17108234 17beta-estradiol multiple interactions ISO RGD:1320286 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of RPL27A mRNA CTD PMID:17404688 2,2',4,4'-Tetrabromodiphenyl ether affects expression EXP 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of RPL27A mRNA CTD PMID:16214954 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1309771 6480464 Tetrachlorodibenzodioxin results in increased expression of RPL27A mRNA CTD PMID:33387578 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1309771 6480464 Tetrachlorodibenzodioxin results in decreased expression of RPL27A mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1320286 6480464 Tetrachlorodibenzodioxin results in decreased expression of RPL27A mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of RPL27A mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of RPL27A mRNA CTD PMID:19465110 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:1309771 6480464 2 more ... CTD PMID:32109520 4,4'-sulfonyldiphenol increases expression ISO RGD:1320286 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of RPL27A protein CTD PMID:34186270 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:1320286 6480464 Oxazolone results in increased expression of RPL27A mRNA CTD PMID:17374397 6-propyl-2-thiouracil increases expression ISO RGD:1309771 6480464 Propylthiouracil results in increased expression of RPL27A mRNA CTD PMID:24780913 acrolein multiple interactions ISO RGD:1320286 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of RPL27A mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of RPL27A mRNA CTD PMID:32699268 alpha-pinene multiple interactions ISO RGD:1320286 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of RPL27A mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of RPL27A mRNA CTD PMID:32699268 ammonium chloride affects expression ISO RGD:1309771 6480464 Ammonium Chloride affects the expression of RPL27A mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:1320286 6480464 aristolochic acid I results in decreased expression of RPL27A protein CTD PMID:33212167 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of RPL27A mRNA CTD PMID:23650126 arsenite(3-) multiple interactions ISO RGD:1320286 6480464 arsenite promotes the reaction [G3BP1 protein binds to RPL27A mRNA] CTD PMID:32406909 benzo[a]pyrene increases expression ISO RGD:1320286 6480464 Benzo(a)pyrene results in increased expression of RPL27A mRNA CTD PMID:20106945 benzo[a]pyrene decreases expression ISO RGD:1320286 6480464 Benzo(a)pyrene results in decreased expression of RPL27A mRNA CTD PMID:21632981 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of RPL27A mRNA CTD PMID:19770486 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1320286 6480464 7 more ... CTD PMID:20018196 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1320286 6480464 7 more ... CTD PMID:19150397 bis(2-chloroethyl) sulfide increases expression ISO RGD:1320286 6480464 Mustard Gas results in increased expression of RPL27A mRNA CTD PMID:12884408 bisphenol A increases expression ISO RGD:1320286 6480464 bisphenol A results in increased expression of RPL27A mRNA CTD PMID:22576693 bisphenol A decreases expression ISO RGD:1309771 6480464 bisphenol A results in decreased expression of RPL27A protein CTD PMID:32145629 bisphenol A decreases expression ISO RGD:1320286 6480464 bisphenol A results in decreased expression of RPL27A mRNA, bisphenol A results in decreased expression of RPL27A protein CTD PMID:29275510 , PMID:34186270 bisphenol A increases expression ISO RGD:1309771 6480464 bisphenol A results in increased expression of RPL27A mRNA CTD PMID:25181051 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of RPL27A mRNA CTD PMID:26063408 bisphenol A decreases methylation ISO RGD:1320286 6480464 bisphenol A results in decreased methylation of RPL27A gene CTD PMID:22576693 Bisphenol B increases expression ISO RGD:1320286 6480464 bisphenol B results in increased expression of RPL27A protein CTD PMID:34186270 bromobenzene increases expression ISO RGD:1309771 6480464 bromobenzene results in increased expression of RPL27A mRNA CTD PMID:16036859 caffeine increases expression ISO RGD:1320286 6480464 Caffeine results in increased expression of RPL27A protein CTD PMID:31195006 caffeine affects phosphorylation ISO RGD:1320286 6480464 Caffeine affects the phosphorylation of RPL27A protein CTD PMID:35688186 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1320286 6480464 CGP 52608 promotes the reaction [RORA protein binds to RPL27A gene] CTD PMID:28238834 chloropicrin decreases expression ISO RGD:1320286 6480464 chloropicrin results in decreased expression of RPL27A mRNA CTD PMID:26352163 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RPL27A mRNA CTD PMID:20938992 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of RPL27A mRNA CTD PMID:28472532 chromium(6+) increases expression ISO RGD:1320286 6480464 chromium hexavalent ion results in increased expression of RPL27A mRNA CTD PMID:30690063 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of RPL27A mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of RPL27A mRNA] CTD PMID:17585979 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of RPL27A mRNA CTD PMID:17585979 cobalt dichloride increases expression ISO RGD:1320286 6480464 cobaltous chloride results in increased expression of RPL27A mRNA CTD PMID:19376846 cyclosporin A decreases expression ISO RGD:1320286 6480464 Cyclosporine results in decreased expression of RPL27A mRNA CTD PMID:25562108 , PMID:27989131 cylindrospermopsin increases expression EXP 6480464 cylindrospermopsin results in increased expression of RPL27A mRNA CTD PMID:20936652 deoxynivalenol decreases expression ISO RGD:1320286 6480464 deoxynivalenol results in decreased expression of RPL27A mRNA CTD PMID:24247028 diuron decreases expression ISO RGD:1320286 6480464 Diuron results in decreased expression of RPL27A mRNA CTD PMID:35967413 dorsomorphin multiple interactions ISO RGD:1320286 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPL27A mRNA CTD PMID:27188386 enzyme inhibitor multiple interactions ISO RGD:1320286 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RPL27A protein CTD PMID:23301498 ethanol multiple interactions EXP 6480464 Ethanol affects the expression of and affects the splicing of RPL27A mRNA CTD PMID:30319688 eugenol increases expression ISO RGD:1320286 6480464 Eugenol results in increased expression of RPL27A mRNA CTD PMID:17374397 folic acid multiple interactions EXP 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 gentamycin increases expression ISO RGD:1309771 6480464 Gentamicins results in increased expression of RPL27A mRNA CTD PMID:22061828 hydrogen peroxide affects expression ISO RGD:1320286 6480464 Hydrogen Peroxide affects the expression of RPL27A mRNA CTD PMID:23410634 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of RPL27A mRNA CTD PMID:20003209 ivermectin decreases expression ISO RGD:1320286 6480464 Ivermectin results in decreased expression of RPL27A protein CTD PMID:32959892 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RPL27A mRNA CTD PMID:20938992 melphalan increases expression ISO RGD:1320286 6480464 Melphalan results in increased expression of RPL27A mRNA CTD PMID:22363485 menadione affects expression ISO RGD:1320286 6480464 Vitamin K 3 affects the expression of RPL27A mRNA CTD PMID:23410634 methidathion decreases expression EXP 6480464 methidathion results in decreased expression of RPL27A mRNA CTD PMID:34813904 methylseleninic acid decreases expression ISO RGD:1320286 6480464 methylselenic acid results in decreased expression of RPL27A mRNA CTD PMID:18548127 miconazole increases expression EXP 6480464 Miconazole results in increased expression of RPL27A mRNA CTD PMID:27462272 N-ethyl-N-nitrosourea increases mutagenesis EXP 6480464 Ethylnitrosourea results in increased mutagenesis of RPL27A gene CTD PMID:21674502 N-nitrosodiethylamine multiple interactions EXP 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of RPL27A mRNA] CTD PMID:17942915 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of RPL27A mRNA CTD PMID:17942915 ozone multiple interactions ISO RGD:1320286 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of RPL27A mRNA more ... CTD PMID:32699268 paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of RPL27A mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of RPL27A mRNA] CTD PMID:17585979 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of RPL27A mRNA CTD PMID:17562736 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL27A mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression ISO RGD:1320286 6480464 perfluorooctanoic acid results in increased expression of RPL27A protein CTD PMID:26879310 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of RPL27A mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:1320286 6480464 Phenylmercuric Acetate results in increased expression of RPL27A mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1320286 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPL27A mRNA CTD PMID:27188386 PhIP increases expression ISO RGD:1309771 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of RPL27A mRNA CTD PMID:15215175 potassium chromate multiple interactions ISO RGD:1320286 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RPL27A mRNA CTD PMID:22079256 potassium chromate increases expression ISO RGD:1320286 6480464 potassium chromate(VI) results in increased expression of RPL27A mRNA CTD PMID:22079256 , PMID:22714537 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of RPL27A mRNA CTD PMID:28903501 progesterone multiple interactions ISO RGD:1320286 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of RPL27A mRNA CTD PMID:17404688 progesterone decreases expression ISO RGD:1320286 6480464 Progesterone results in decreased expression of RPL27A mRNA CTD PMID:17404688 quercetin increases expression ISO RGD:1320286 6480464 Quercetin results in increased expression of RPL27A mRNA CTD PMID:21632981 rotenone decreases expression ISO RGD:1320286 6480464 Rotenone results in decreased expression of RPL27A mRNA CTD PMID:29955902 rotenone decreases expression ISO RGD:1309771 6480464 Rotenone results in decreased expression of RPL27A protein CTD PMID:35544339 SB 431542 multiple interactions ISO RGD:1320286 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPL27A mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1320286 6480464 Silicon Dioxide analog results in increased expression of RPL27A mRNA CTD PMID:25895662 sodium arsenite increases expression ISO RGD:1309771 6480464 sodium arsenite results in increased expression of RPL27A mRNA CTD PMID:19072884 sodium arsenite decreases expression ISO RGD:1309771 6480464 sodium arsenite results in decreased expression of RPL27A mRNA CTD PMID:35314868 sodium arsenite multiple interactions ISO RGD:1320286 6480464 sodium arsenite results in decreased expression of and results in increased activity of RPL27A protein CTD PMID:30528433 tert-butyl hydroperoxide affects expression ISO RGD:1320286 6480464 tert-Butylhydroperoxide affects the expression of RPL27A mRNA CTD PMID:23410634 thapsigargin affects expression ISO RGD:1320286 6480464 Thapsigargin affects the expression of RPL27A mRNA CTD PMID:24247028 thioacetamide increases expression ISO RGD:1309771 6480464 Thioacetamide results in increased expression of RPL27A mRNA CTD PMID:34492290 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of RPL27A mRNA CTD PMID:27760801 Tributyltin oxide decreases expression ISO RGD:1320286 6480464 bis(tri-n-butyltin)oxide results in decreased expression of RPL27A mRNA CTD PMID:24247028 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of RPL27A mRNA CTD PMID:19448997 tungsten increases expression EXP 6480464 Tungsten results in increased expression of RPL27A mRNA CTD PMID:30912803 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of RPL27A mRNA CTD PMID:17963808 valproic acid increases expression ISO RGD:1320286 6480464 Valproic Acid results in increased expression of RPL27A mRNA CTD PMID:23179753 valproic acid affects expression ISO RGD:1320286 6480464 Valproic Acid affects the expression of RPL27A mRNA CTD PMID:25979313
